IGC Pharma (IGC) Operating Leases (2020 - 2025)
IGC Pharma (IGC) reported Operating Leases of $2000.0 for Q4 2025, down 83.33% year-over-year from $12000.0 in Q4 2024, and down 60.0% quarter-over-quarter from $5000.0 in Q3 2025.
IGC Pharma (IGC) Operating Leases (2020 - 2025) Analysis & Trends
IGC Pharma (IGC) has 6 years of Operating Leases data on file, last reported at $2000.0 in Q4 2025.
- Operating Leases for Q4 2025 came in at $2000.0, down 83.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $2000.0 (down 83.33% YoY), and the FY2025 annual result was $10000.0, down 88.1% from the prior year.
- Operating Leases slipped to $2000.0 in Q4 2025 per IGC's latest filing, from $5000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $433000.0 in Q2 2021 and troughed at $2000.0 in Q4 2025.
- A 5-year average of $182600.0 and a median of $162500.0 in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2021 and 2025: Operating Leases dropped 8.07% in 2021, then sank 89.86% in 2025.
- A 5-year view of Operating Leases shows it stood at $374000.0 in 2021, then plunged by 35.56% to $241000.0 in 2022, then sank by 52.28% to $115000.0 in 2023, then sank by 89.57% to $12000.0 in 2024, then tumbled by 83.33% to $2000.0 in 2025.
- Business Quant data shows IGC's Operating Leases at $2000.0 in Q4 2025, $5000.0 in Q3 2025, and $7000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Dec 31, 2023 | 115,000.00 |
| Sep 30, 2023 | 146,000.00 |
| Jun 30, 2023 | 179,000.00 |
| Mar 31, 2023 | 207,000.00 |
| Dec 31, 2022 | 241,000.00 |
| Sep 30, 2022 | 275,000.00 |
| Jun 30, 2022 | 308,000.00 |
| Mar 31, 2022 | 341,000.00 |
| Dec 31, 2021 | 374,000.00 |
| Sep 30, 2021 | 404,000.00 |
| Jun 30, 2021 | 433,000.00 |
| Mar 31, 2021 | 405,000.00 |